T. Xu

A Novel Ferroptosis-Related Gene Signature to Predict Prognosis of Esophageal Carcinoma

F. Sun, Ziming Guo, Jingping Yu, 2022, Journal of oncology.

Development and validation of a radiomics-based nomogram for predicting a major pathological response to neoadjuvant immunochemotherapy for patients with potentially resectable non-small cell lung cancer

J. Liu, Chang Li, Wei Zhao, 2023, Frontiers in Immunology.

Primary results of ALESIA: A randomised, phase III, open-label study of alectinib vs crizotinib in Asian patients with treatment-naïve ALK+ advanced NSCLC.

L. Zhang, Se-Hoon Lee, C. Zhou, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

1377P Preliminary efficacy and safety results of KN026 (a HER2-targeted bispecific antibody) in combination with KN046 (an anti-PD-L1/CTLA-4 bispecific antibody) in patients (pts) with HER2-positive gastrointestinal tumors

L. Kong, S. Luo, L. Shen, 2021, Annals of Oncology.

Primary results of ALESIA: Phase III, randomised open-label study of alectinib (ALC) vs crizotinib (CRZ) in Asian patients (pts) with treatment-naïve ALK+ advanced non-small-cell lung cancer (NSCLC).

Se-Hoon Lee, C. Zhou, Y. Cheng, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Allergy and risk of glioma: a meta‐analysis

Juxiang Chen, Tao Xu, Chao Chen, 2011, European journal of neurology.

Incidental Use of Beta-Blockers, Serum VEGF, and Their Association With Disease Outcome in Patients with Non-Small-Cell Lung Cancer Treated with Definitive Chemoradiation Therapy.

D. Gomez, Z. Liao, J. Huo, 2017, International Journal of Radiation Oncology, Biology, Physics.